The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
COX-2 Inhibitors and Cardiovascular Risk
Abstract
Placebo-controlled trials of nonsteroidal antiinflammatory drugs (NSAIDs) selective for COX-2 have revealed an enhanced risk for cardiovascular events. COX-2 inhibitors (coxibs) selectively reduce vascular prostacyclin synthesis without disrupting COX-1-derived thromboxane synthesis in platelets. Removal of prostacyclin's capacity to restrain all known endogenous compounds contributing to platelet activation and vasoconstriction is a well-recognized mechanism for coxib action in the cardiovascular system which can pre-dispose to thrombosis, hypertension and atherosclerosis. Novel mouse models of selective COX-2 inhibition and disruption of microsomal prostaglandin E synthase-1 have been exploited to reveal the relative importance of prostacyclin and prostaglandin E2 in cardiovascular homeostasis. This review discusses the background to our current understanding of coxibs and provides further information relating to recent mechanistic insights into how COX-2 inhibition promotes cardiovascular risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Self-citationMoncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Hamberg, M., Svensson, J., & Samuelsson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2994 · Cited by 3,045
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,264
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,978
Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960803q · Cited by 1,965
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050613 · Cited by 1,945
Needleman, P., Truk, J., Jakschik, B. A., Morrison, A. R., & Lefkowith, J. B. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.000441 · Cited by 1,807
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Self-citationSeibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Hla, T., & Neilson, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7384 · Cited by 1,465
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Self-citationSelective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Self-citationRandomised trial of prophylactic daily aspirin in British male doctors
Peto, R., Gray, R., Collins, R., Wheatley, K., Hennekens, C., Jamrozik, K., Warlow, C., Hafner, B., Thompson, E., Norton, S., et al. (1988) · BMJ · doi:10.1136/bmj.296.6618.313 · Cited by 1,166
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Napoli, C., D'Armiento, F. P., Mancini, F. P., Postiglione, A., Witztum, J. L., Palumbo, G., & Palinski, W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119813 · Cited by 1,014
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.
Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., & Needleman, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44821-6 · Cited by 944
Moncada, S., Higgs, E. A., & Vane, J. R. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91655-5 · Cited by 882
Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., Dubois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 860
Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro.
Davies, P. F., Remuzzi, A., Gordon, E. J., Dewey, C. F., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.7.2114 · Cited by 847
Topper, J. N., Cai, J., Falb, D., & Gimbrone, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10417 · Cited by 843
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A. (2002) · Science · doi:10.1126/science.1068711 · Cited by 789
Self-citationAllakhverdi, Z., Comeau, M. R., Jessup, H. K., Yoon, B.-R. P., Brewer, A., Chartier, S., Paquette, N., Ziegler, S. F., Sarfati, M., & Delespesse, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062211 · Cited by 786
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
The chemical structure of prostaglandin X (prostacyclin)
Johnson, R. A., Morton, D. R., Kinner, J. H., et al. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90126-x · Cited by 729
Jones, D. A., Carlton, D. P., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52976-8 · Cited by 708
Moncada, S., Herman, A. G., Higgs, E. A., & Vane, J. R. (1977) · Thrombosis Research · doi:10.1016/0049-3848(77)90185-2 · Cited by 680
FitzGerald, G. A., Oates, J. A., Hawiger, J., Maas, R. L., Roberts, L. J., Lawson, J. A., & Brash, A. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110814 · Cited by 665
Self-citationCrofford, L. J., Wilder, R. L., Ristimäki, A. P., Sano, H., Remmers, E. F., Epps, H. R., & Hla, T. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117060 · Cited by 655
Talley, J. J., Brown, D. L., Carter, J. S., Graneto, M. J., Koboldt, C. M., Masferrer, J. L., Perkins, W. E., Rogers, R. S., Shaffer, A. F., Zhang, Y. Y., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990577v · Cited by 638
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
Self-citationDeWitt, D. L., & Smith, W. L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1412 · Cited by 596
Funk, C. D., Funk, L. B., Kennedy, M. E., Pong, A. S., & Fitzgerald, G. A. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.9.1907252 · Cited by 571
Self-citationNeedleman, P., Moncada, S., Bunting, S., Vane, J. R., Hamberg, M., & Samuelsson, B. (1976) · Nature · doi:10.1038/261558a0 · Cited by 526
COX-2 and beyond: approaches to prostaglandin inhibition in human disease
FitzGerald, G. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1225 · Cited by 518
Self-citationPatrignani, P., Panara, M. R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Créminon, C., & Maclouf, J. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24061-7 · Cited by 518
Biosynthesis of Prostaglandins
Lands, W. E. M. (1991) · Annual Review of Nutrition · doi:10.1146/annurev.nu.11.070191.000353 · Cited by 507
Fletcher, B. S., Kujubu, D. A., Perrin, D. M., & Herschman, H. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42840-2 · Cited by 491
Bergström, S., Danielsson, H., & Samuelsson, B. (1964) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(64)90145-x · Cited by 481
Effects of Anti-inflammatory Drugs on Prostaglandin Biosynthesis
FLOWER, R., GRYGLEWSKI, R., HERBACZŃSKA-CEDRO, K., & VANE, J. R. (1972) · Nature New Biology · doi:10.1038/newbio238104a0 · Cited by 475
Felson, D. T., Anderson, J. J., Lange, M. L. M., Wells, G., & LaValley, M. P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9 · Cited by 474
Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation.
Ristimäki, A., Garfinkel, S., Wessendorf, J., Maciag, T., & Hla, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32638-8 · Cited by 473
Laneuville, O., Breuer, D. K., Dewitt, D. L., Hla, T., Funk, C. D., & Smith, W. L. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23861-7 · Cited by 472
Self-citationRiendeau, D., Percival, M. D., Brideau, C., Charleson, S., Dubé, D., Ethier, D., Falgueyret, J.-P., Friesen, R. W., Gordon, R., Greig, G., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38776-2 · Cited by 460
COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice
Egan, K. M., Lawson, J. A., Fries, S., Koller, B., Rader, D. J., Smyth, E. M., & FitzGerald, G. A. (2004) · Science · doi:10.1126/science.1103333 · Cited by 431
Self-citationMerlie, J. P., Fagan, D., Mudd, J., & Needleman, P. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68959-8 · Cited by 429
Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
Copeland, R. A., Williams, J. M., Giannaras, J., Nurnberg, S., Covington, M., Pinto, D., Pick, S., & Trzaskos, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11202 · Cited by 408
Chan, C.-C., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Ford-Hutchinson, A. W., Forrest, M. J., Gauthier, J. Y., et al. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34934-1 · Cited by 398
The biosynthesis of prostaglandins
Van Dorp, D. A., Beerthuis, R. K., Nugteren, D. H., & Vonkeman, H. (1964) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(64)90144-8 · Cited by 392
Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
Schönbeck, U., Sukhova, G. K., Graber, P., Coulter, S., & Libby, P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65230-3 · Cited by 379
Cyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis
Belton, O., Byrne, D., Kearney, D., Leahy, A., & Fitzgerald, D. J. (2000) · Circulation · doi:10.1161/01.cir.102.8.840 · Cited by 377
Kobayashi, T., Tahara, Y., Matsumoto, M., Iguchi, M., Sano, H., Murayama, T., Arai, H., Oida, H., Yurugi-Kobayashi, T., Yamashita, J. K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421446 · Cited by 373
Passerini, A. G., Polacek, D. C., Shi, C., Francesco, N. M., Manduchi, E., Grant, G. R., Pritchard, W. F., Powell, S., Chang, G. Y., Stoeckert, C. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305938101 · Cited by 362
Post-transcriptional Control of Cyclooxygenase-2 Gene Expression
Dixon, D. A., Kaplan, C. D., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11750 · Cited by 349
Suppression of Thromboxane A2but Not of Systemic Prostacyclin by Controlled-Release Aspirin
Clarke, R. J., Mayo, G., Price, P., & FitzGerald, G. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251605 · Cited by 346
Self-citationCyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
Cheng, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27540 · Cited by 339
Yokoyama, C., & Tanabe, T. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(89)80049-x · Cited by 332
Jongstra-Bilen, J., Haidari, M., Zhu, S.-N., Chen, M., Guha, D., & Cybulsky, M. I. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060245 · Cited by 330
Leukotriene modifiers as potential therapeutics for cardiovascular disease
Funk, C. D. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1796 · Cited by 326
Self-citationEHRICH, E., DALLOB, A., DELEPELEIRE, I., VANHECKEN, A., RIENDEAU, D., YUAN, W., PORRAS, A., WITTREICH, J., SEIBOLD, J., & DESCHEPPER, P. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70113-x · Cited by 322
SPATIAL RELATIONSHIPS IN EARLY SIGNALING EVENTS OF FLOW-MEDIATED ENDOTHELIAL MECHANOTRANSDUCTION
Davies, P. F., Barbee, K. A., Volin, M. V., Robotewskyj, A., Chen, J., Joseph, L., Griem, M. L., Wernick, M. N., Jacobs, E., Polacek, D. C., et al. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.527 · Cited by 322
Baker, C. S. R., Hall, R. J. C., Evans, T. J., Pomerance, A., Maclouf, J., Creminon, C., Yacoub, M. H., & Polak, J. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.646 · Cited by 296
Prostaglandins and the mechanism of analgesia produced by aspirin‐like drugs
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1973) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1973.tb08270.x · Cited by 296
Prostaglandins and the mechanism of analgesia produced by aspirin‐like drugs
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1997) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1997.tb06823.x · Cited by 292
Kinetic basis for selective inhibition of cyclo-oxygenases
Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K., & Isakson, P. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3390607 · Cited by 287
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
Catella, F., Healy, D., Lawson, J. A., & FitzGerald, G. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5861 · Cited by 286
Self-citationTHE PROSTACYCLIN-THROMBOXANE A2 BALANCE: PATHOPHYSIOLOGICAL AND THERAPEUTIC IMPLICATIONS
BUNTING, S., MONCADA, S., & VANE, J. R. (1983) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071832 · Cited by 283
Cyclooxygenase Inhibition and Cardiovascular Risk
Antman, E. M., DeMets, D., & Loscalzo, J. (2005) · Circulation · doi:10.1161/circulationaha.105.568451 · Cited by 282
Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice
Burleigh, M. E., Babaev, V. R., Oates, J. A., Harris, R. C., Gautam, S., Riendeau, D., Marnett, L. J., Morrow, J. D., Fazio, S., & Linton, M. F. (2002) · Circulation · doi:10.1161/01.cir.0000014927.74465.7f · Cited by 279
Brideau, C., Kargman, S., Liu, S., Dallob, A. L., Ehrich, E. W., Rodger, I. W., & Chan, C. C. (1996) · Inflammation Research · doi:10.1007/bf02265118 · Cited by 279
MONCADA, S. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09186.x · Cited by 272
Estimated rate of prostacyclin secretion into the circulation of normal man.
FitzGerald, G. A., Brash, A. R., Falardeau, P., & Oates, J. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110373 · Cited by 269
Self-citationBolli, R. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00414-5 · Cited by 258
Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II
Qi, Z., Hao, C., Langenbach, R. I., BREYER, R. M., Redha, R., Morrow, J. D., & Breyer, M. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14752 · Cited by 249
Estimated rate of thromboxane secretion into the circulation of normal humans.
Patrono, C., Ciabattoni, G., Pugliese, F., Pierucci, A., Blair, I. A., & FitzGerald, G. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112341 · Cited by 234
Self-citationRaz, A., Wyche, A., & Needleman, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1657 · Cited by 227
Loftin, C. D., Trivedi, D. B., Tiano, H. F., Clark, J. A., Lee, C. A., Epstein, J. A., Morham, S. G., Breyer, M. D., Nguyen, M., Hawkins, B. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1059 · Cited by 219
Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis
Wang, M., Zukas, A. M., Hui, Y., Ricciotti, E., Puré, E., & FitzGerald, G. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606586103 · Cited by 205
Self-citationEgan, K. M., Wang, M., Lucitt, M. B., Zukas, A. M., Puré, E., Lawson, J. A., & FitzGerald, G. A. (2005) · Circulation · doi:10.1161/01.cir.0000153386.95356.78 · Cited by 193
Self-citationPharmacodynamic of cyclooxygenase inhibitors in humans
Capone, M. L., Tacconelli, S., Di Francesco, L., Sacchetti, A., Sciulli, M. G., & Patrignani, P. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.019 · Cited by 190
Riendeau, D., Charleson, S., Cromlish, W., Mancini, J. A., Wong, E., & Guay, J. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-9-1088 · Cited by 186
Baenziger, N. L., Becherer, P. R., & Majerus, P. W. (1979) · Cell · doi:10.1016/0092-8674(79)90111-9 · Cited by 183
Yokoyama, U., Minamisawa, S., Quan, H., Ghatak, S., Akaike, T., Segi-Nishida, E., Iwasaki, S., Iwamoto, M., Misra, S., Tamura, K., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28639 · Cited by 169
Kujubu, D. A., Reddy, S. T., Fletcher, B. S., & Herschman, H. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53338-x · Cited by 167
Hennan, J. K., Huang, J., Barrett, T. D., Driscoll, E. M., Willens, D. E., Park, A. M., Crofford, L. J., & Lucchesi, B. R. (2001) · Circulation · doi:10.1161/hc3301.092790 · Cited by 163
Pidgeon, G. P., Tang, K., Cai, Y. L., Piasentin, E., & Honn, K. V. (2003) · PubMed · Cited by 156
Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation
Rosen, G. D., Birkenmeier, T. M., Raz, A., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91819-6 · Cited by 152
Prostacyclin protects against elevated blood pressure and cardiac fibrosis
Francois, H., Athirakul, K., Howell, D. N., Dash, R., Mao, L., Kim, H., Rockman, H. A., FitzGerald, G. A., Koller, B. H., & Coffman, T. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.005 · Cited by 151
Self-citationInoue, H., Taba, Y., Miwa, Y., Yokota, C., Miyagi, M., & Sasaguri, T. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000028816.13582.13 · Cited by 131
Wright, L. A., Tuder, R. M., WANG, J., Cool, C. D., Lepley, R. A., & Voelkel, N. F. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704003 · Cited by 127
Mbonye, U. R., Wada, M., Rieke, C. J., Tang, H.-Y., DeWitt, D. L., & Smith, W. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608281200 · Cited by 125
5-Lipoxygenase and atherosclerosis
Mehrabian, M., & Allayee, H. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00005 · Cited by 118
COX-2–Derived Prostacyclin Modulates Vascular Remodeling
Rudic, R. D., Brinster, D. R., Cheng, Y., Fries, S., Song, W., Austin, S. C., Coffman, T. M., & FitzGerald, G. A. (2005) · Circulation Research · doi:10.1161/01.res.0000170888.11669.28 · Cited by 116
Self-citationWalter, M. F., Jacob, R. F., Day, C. A., Dahlborg, R., Weng, Y., & Mason, R. P. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.001 · Cited by 115
Fujino, T., Nakagawa, N., Yuhki, K., Hara, A., Yamada, T., Takayama, K., Kuriyama, S., Hosoki, Y., Takahata, O., Taniguchi, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21382 · Cited by 114
Molecular Cloning and Expression of Human Prostacyclin Synthase
Miyata, A., Hara, S., Yokoyama, C., Inoue, H., Ullrich, V., & Tanabe, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1652 · Cited by 111
Steffel, J., Hermann, M., Greutert, H., Gay, S., Lüscher, T. F., Ruschitzka, F. T., & Tanner, F. C. (2005) · Circulation · doi:10.1161/01.cir.0000160358.63804.c9 · Cited by 109
Eilertsen, K., & Østerud, B. (2004) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200410000-00001 · Cited by 109
The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis
LOTZER, K., FUNK, C., & HABENICHT, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.07.001 · Cited by 108
Self-citationMeasurement of renal and non-renal eicosanoid synthesis
Catella, F., Nowak, J., & FitzGerald, G. A. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90905-8 · Cited by 108
Self-citationBalancing prostanoid activity in the human vascular system
Flavahan, N. A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.01.003 · Cited by 104
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice
Burleigh, M. E., Babaev, V. R., Yancey, P. G., Major, A. S., McCaleb, J. L., OATES, J., Morrow, J. D., Fazio, S., & Linton, M. F. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.06.011 · Cited by 101
Inhibition of Cyclooxygenase-2 in the Rat Renal Medulla Leads to Sodium-Sensitive Hypertension
Zewde, T., & Mattson, D. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000140924.91479.03 · Cited by 98
Pidgeon, G. P., Tamošiūnienė, R., Chen, G., Leonard, I., Belton, O., Bradford, A., & Fitzgerald, D. J. (2004) · Circulation · doi:10.1161/01.cir.0000145613.01188.0b · Cited by 96
Metabolic disposition of prostacyclin in humans.
Brash, A. R., Jackson, E. K., Saggese, C. A., Lawson, J. A., Oates, J. A., & FitzGerald, G. A. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21477-x · Cited by 94
Self-citationThe Biochemical Selectivity of Novel COX-2 Inhibitors in Whole Blood Assays of COX-isozyme Activity
Tacconelli, S., Capone, M. L., Sciulli, M. G., Ricciotti, E., & Patrignani, P. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125001335 · Cited by 92
Mason, R. P., Walter, M. F., McNulty, H. P., Lockwood, S. F., Byun, J., Day, C. A., & Jacob, R. F. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200605001-00003 · Cited by 86
Expression of Cyclo-oxygenase-2 in Human Atherosclerotic Carotid Arteries
Stemme, V., Swedenborg, J., Claesson, H. E., & Hansson, G. K. (2000) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2000.1145 · Cited by 84
Rabausch, K., Bretschneider, E., Sarbia, M., Meyer-Kirchrath, J., Censarek, P., Pape, R., Fischer, J. W., Schrör, K., & Weber, A. (2005) · Circulation Research · doi:10.1161/01.res.0000153150.27690.f2 · Cited by 84
Zarraga, I. G. E., & Schwarz, E. R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.003 · Cited by 82
Mitchell, J. A., Lucas-Domínguez, R., Vojnovic, I., Hasan, K., Pepper, J., & Warner, T. D. (2006) · The FASEB Journal · doi:10.1096/fj.06-6615com · Cited by 82
Rott, D., Zhu, J., Burnett, M. S., Zhou, Y., Zalles-Ganley, A., Ogunmakinwa, J., & Epstein, S. E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00304-8 · Cited by 80
Valdecoxib: Assessment of Cyclooxygenase-2 Potency and Selectivity
Gierse, J. K., Zhang, Y., Hood, W. F., Walker, M. C., Trigg, J. S., Maziasz, T. J., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Masferrer, J. L., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076877 · Cited by 80
Genetic model of selective COX2 inhibition reveals novel heterodimer signaling
Yu, Y., Fan, J., Chen, X., Wang, D., Klein–Szanto, A. J., Campbell, R. L., FitzGerald, G. A., & Funk, C. D. (2006) · Nature Medicine · doi:10.1038/nm1412 · Cited by 78
Self-citationTherland, K. L., Stubbe, J., Thiesson, H. C., Ottosen, P. D., Walter, S., Sørensen, G. L., Skøtt, O., & Jensen, B. L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000124673.79934.24 · Cited by 73
Bea, F., Blessing, E., Bennett, B. J., Kuo, C. C., Campbell, L. A., Kreuzer, J., & Rosenfeld, M. E. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00464-4 · Cited by 67
Krendel, M., Gloushankova, N. A., Bonder, E. M., Feder, H. H., Vasiliev, J. M., & Gelfand, I. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9666 · Cited by 64
Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man.
Roy, L., Knapp, H. R., Robertson, R. M., & FitzGerald, G. A. (1985) · Circulation · doi:10.1161/01.cir.71.3.434 · Cited by 64
Self-citationKothapalli, D., Stewart, S. A., Smyth, E. M., Azonobi, I., Rader, D. J., Puré, E., & Assoian, R. K. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.249 · Cited by 61
Targeted Cyclooxygenase Gene (Ptgs) Exchange Reveals Discriminant Isoform Functionality
Yu, Y., Fan, J., Hui, Y., Rouzer, C. A., Marnett, L. J., Klein–Szanto, A. J., FitzGerald, G. A., & Funk, C. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609930200 · Cited by 60
Self-citationInduction of Cyclooxygenase-2 in Human Saphenous Vein and Internal Mammary Artery
Bishop‐Bailey, D., Pepper, J., Haddad, E. B., Newton, R. C., Larkin, S. W., & Mitchell, J. A. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1644 · Cited by 60
Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors
Mais, D. E., Halushka, P. V., & Saussy, D. L. (1988) · Springer eBooks · doi:10.1007/978-94-009-1285-4_9 · Cited by 51
No Effect of Cyclooxygenase Inhibition on Plaque Size in Atherosclerosis-prone Mice
Olesen, M., Kwong, E. C., Meztli, A., Kontny, F. P., Seljeflot, I., Arnesen, H., Lyngdorf, L. G., & Falk, E. (2002) · Scandinavian Cardiovascular Journal · doi:10.1080/140174302762659094 · Cited by 47
Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men
Knapp, H. R., Healy, C. T., Lawson, J. A., & FitzGerald, G. A. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90267-8 · Cited by 47
Self-citationEicosanoid biosynthesis in human cardiovascular disease
FitzGerald, G. A., Catella, F., & Oates, J. A. (1987) · Human Pathology · doi:10.1016/s0046-8177(87)80007-2 · Cited by 42
Self-citationKawka, D. W., Ouellet, M., Hétu, P., Singer, I. I., & Riendeau, D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.09.015 · Cited by 40
Metzner, J., Popp, L., Marian, C., Schmidt, R., Manderscheid, C., Renné, C., Fißlthaler, B., Fleming, I., Busse, R., Geißlinger, G., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0162-9 · Cited by 32
Effects of Salt Loading on Blood Pressure in Mice Lacking the Prostanoid Receptor Gene
Watanabe, H., Katoh, T., Eiro, M., Iwamoto, M., Ushikubi, F., Narumiya, S., & Watanabe, T. (2004) · Circulation Journal · doi:10.1253/circj.69.124 · Cited by 29
Role of thromboxane A2 in mitogenesis of vascular smooth muscle cells
Dorn, G. W. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7352-9_3 · Cited by 22
Vascular endothelium: in defense of blood fluidity.
Schafer, A. I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119266 · Cited by 20
Effects of prostacyclin analogues on human endothelial cell tissue factor expression.
Crutchley, D. J., Conanan, L. B., Toledo, A., Solomon, D. E., & Que, B. G. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.7.1082 · Cited by 18
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Self-citationThe Endothelium and Its Role in Regulating Vascular Tone
Sandoo, A., Veldhuijzen van Zanten, J. J. C. S., Metsios, G. S., Carroll, D., & Kitas, G. D. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010302 · Cited by 814
Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions
Xu, Z.-Z., Zhang, L., Liu, T., Park, J. Y., Berta, T., Yang, R., Serhan, C. N., & Ji, R.-R. (2010) · Nature Medicine · doi:10.1038/nm.2123 · Cited by 591
Inflammatory mediators in the pathogenesis of periodontitis
Yucel-Lindberg, T., & Båge, T. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.8 · Cited by 472
Endothelium‐mediated control of vascular tone: COX‐1 and COX‐2 products
Félétou, M., Huang, Y., & Vanhoutte, P. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01276.x · Cited by 372
Metadata
- Authors
- Funk, C. D., & FitzGerald, G. A.
- Venue
- Journal of Cardiovascular Pharmacology
- Published
- 2007-11
- Volume
- 50
- Issue
- 5
- Pages
- 470-479
- ISSN
- 0160-2446 (ISSN-L)
- OpenAlex
- W2080513230
- Cited by
- 330
- References
- 140
- FWCI
- 12.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.